반응식
[NH:1]1[C:9]2[C:4](=[CH:5][C:6]([NH:10][CH:11]3[CH2:16][CH2:15][C:14](=O)[CH2:13][CH2:12]3)=[CH:7][CH:8]=2)[CH:3]=[N:2]1.[CH:18]1([NH2:24])[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].Cl.CO>CO>[CH:18]1([NH:24][CH:14]2[CH2:15][CH2:16][CH:11]([NH:10][C:6]3[CH:5]=[C:4]4[C:9](=[CH:8][CH:7]=3)[NH:1][N:2]=[CH:3]4)[CH2:12][CH2:13]2)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]1참가 물질
실험 절차
4-(1H-5-Indazolylamino)-1-cyclohexanone (intermediate 3) (57 mg) and cyclohexylamine (50 mg) were dissolved in methanol (1 ml), and sodium triacetoxyborohydride (105 mg) was added by portions to the solution at room temperature. The reaction mixture was stirred at room temperature for 18 hr. Hydrochloric acid-methanol was then added thereto, and the reaction mixture was stirred and was then concentrated. The residue was purified by HPLC [0.5% aqueous trifluoroacetic acid solution/acetonitrile]. A saturated aqueous sodium hydrogencarbonate solution (2 ml) was then added to fractions containing respective compounds, followed by extraction with chloroform-propanol (3/1). The organic layers were dried over anhydrous sodium sulfate, and the solvent was removed by distillation under the reduced pressure to give an antiform compound (22 mg) and a syn-form compound (23 mg).
후처리
- stirringthe reaction mixture was stirred
- concentrationwas then concentrated
- customThe residue was purified by HPLC [0.5% aqueous trifluoroacetic acid solution/acetonitrile]
- additionA saturated aqueous sodium hydrogencarbonate solution (2 ml) was then added to fractions
- additioncontaining respective compounds
- extractionfollowed by extraction with chloroform-propanol (3/1)
- dry with materialThe organic layers were dried over anhydrous sodium sulfate
- customthe solvent was removed by distillation under the reduced pressure
출처 및 근거
- ORD 기록
- ord-31f02682d6eb468881fb8077b1e3e10f
- 출처 데이터셋
- uspto-grants-2007_05
- 특허 번호
- US07217722B2
연결된 노트
불러오는 중…